Oligonucleotide therapies: a new class of drugs that allow precise genetic targeting
Pharmacology seminar by Annemieke Aartsma-Rus, Leiden University Medical Center, the Netherlands
Hosted by ERN-RND
Tuesday 17:00–18:10 Paris (GMT+2)
Recording available
ZA Leiden, Netherlands · Hybrid
Related seminars
Seminar
Targeting alternative splicing of SYNGAP1 using antisense oligonucleotides
Benjamin Prosser, University of Pennsylvania Perelman School of Medicine, PhD · Recording · Sep 29, 2022
More from ERN-RND
All talksClinical and genetic predictors of subthalamic nucleus deep brain stimulation in Parkinson’s disease
Recording · Sep 27, 2022Daniel WeißImportance of autopsies in leukodystrophies
Recording · Jul 12, 2022Marianna BugianiBiofluid biomarkers in atypical parkinsonism
Recording · Jun 21, 2022Per SvenningssonMitochondrial leukodystrophies
Recording · May 24, 2022Anna Ardissone
More with Annemieke Aartsma-Rus
All their workUpcoming in Pharmacology
All seminarsAutomated X-ray fragment and ligand screening for therapeutic innovation in infection biology
Oct 28, 2026José MárquezNeuromodulation of Circuit Plasticity: From Adaptive Behavior to Precision Therapeutics
Dec 2, 2026Kuan Hong WangDiscovery and Variant Effect Prediction with the next generation of ProtVar
Dec 3, 2026James Stephenson
Conferences in Pharmacology soon
All conferencesHighlights in Medicinal Chemistry VI
Oct 8, 2026SCI, 14/15 Belgrave Square, London SW1X 8PS, United KingdomAAPS 2026 PharmSci 360
Oct 25–28, 2026Ernest N. Morial Convention Center, New Orleans, Louisiana, United StatesNeurodevelopmental Disorders: Mechanisms and Therapeutics
Jan 19–22, 2027Beaver Run Conference Center, Breckenridge, Colorado, United StatesCancer Neuroscience: Neural Mechanisms as Therapeutic Targets in Cancer
Feb 21–24, 2027Keystone Resort, Keystone, Colorado, United States